ACM
AKYA

Aquatic Capital Management’s Akoya BioSciences AKYA Stock Holding History

Aquatic Capital Management’s Portfolio AKYA Stock Details AKYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-400
Closed -$3K – 1211
2023
Q2 		$3K Buy
+400
New +$2.67K ﹤0.01% 1265
2023
Q1 		– Sell
-2,800
Closed -$27K – 1219
2022
Q4 		$27K Buy
+2,800
New +$34.5K ﹤0.01% 1117

Other funds holding AKYA

BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return

Aquatic Capital Management's AKYA Position: Q3 2023 in Review

Aquatic Capital Management sold out of Akoya BioSciences (AKYA) in Q3 2023, closing a stake of 400 shares — an estimated $3K sold.

Aquatic Capital Management first reported a position in AKYA in Q4 2022 and held it in 2 quarters. The position peaked at $27K in Q4 2022. 62 funds tracked by Wall St. Rank hold AKYA as of Q3 2023.

  • Aquatic Capital Management reported no remaining Akoya BioSciences position as of Q3 2023 after selling out during the quarter.
  • Aquatic Capital Management sold 400 Akoya BioSciences shares in Q3 2023, an estimated $3K.
  • Aquatic Capital Management first reported a position in Akoya BioSciences in Q4 2022 and held it in 2 quarters.
  • Aquatic Capital Management's Akoya BioSciences position peaked at $27K in Q4 2022.
  • 62 funds tracked by Wall St. Rank held Akoya BioSciences as of Q3 2023.

Based on Aquatic Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.